- Medical University of Lodz
Main area of scientific interests concerns hypertension aspects (risk stratification, prehypertension, new biomarkers, optimal level of BP - J-curve phenomenon, pharmacotherapy/combined therapy, prevention, complications), lipid disorders (risk stratification, new biomarkers, diagnosis, rare diseases), dyslipidemia therapy (statins, new drugs, combined treatment) and new drugs in CVD therapy.
|Sep. 12 (Sat)
Novel Role of HDL – Clinical Perspectives
||International Lipid Expert Panel (ILEP) 2020 Guidelines on the Definition and Management With Statin Intolerance